Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

PRESIDENT, DRUG DEV SOLUTIONS

CHIEF EXECUTIVE OFFICER

PRESIDENT; SCIENTIFIC SOFTWARE

CHIEF FINANCIAL OFFICER

SVP AND GENERAL COUNSEL

CHIEF HUMAN RESOURCES OFFICER

PRESIDENT, CHIEF COMMERCAL OFF

PRESIDENT, SIMCYP

PRESIDENT, INTEGRATED DRUG DEV

PRESIDENT, SOFTWARE

PRESIDENT, REG & ACCES

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, the Netherlands, the Philippines, Poland, Portugal, Spain, Switzerland, and the United Kingdom. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation i...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-02	Premium	sold	Premium	Premium	Premium	PRESIDENT, DRUG DEV SOLUTIONS
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-01	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-01	Premium	acquired	Premium	Premium	Premium	PRESIDENT; SCIENTIFIC SOFTWARE
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-04-01	Premium	acquired	Premium	Premium	Premium	SVP AND GENERAL COUNSEL
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF HUMAN RESOURCES OFFICER
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	PRESIDENT, CHIEF COMMERCAL OFF
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	PRESIDENT, DRUG DEV SOLUTIONS
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	PRESIDENT; SCIENTIFIC SOFTWARE
2024-04-01	Premium	sold	Premium	Premium	Premium	SVP AND GENERAL COUNSEL
2024-04-01	Premium	acquired	Premium	Premium	Premium	CHIEF HUMAN RESOURCES OFFICER
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	SVP AND GENERAL COUNSEL
2024-04-01	Premium	acquired	Premium	Premium	Premium	PRESIDENT, CHIEF COMMERCAL OFF
2024-04-01	Premium	acquired	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-04-01	Premium	acquired	Premium	Premium	Premium	PRESIDENT, DRUG DEV SOLUTIONS
2024-03-05	Premium	acquired	Premium	Premium	Premium	PRESIDENT, CHIEF COMMERCAL OFF
2024-03-05	Premium	acquired	Premium	Premium	Premium	PRESIDENT; SCIENTIFIC SOFTWARE
2024-03-05	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF HUMAN RESOURCES OFFICER
2024-03-05	Premium	acquired	Premium	Premium	Premium	CHIEF HUMAN RESOURCES OFFICER
2024-03-05	Premium	sold (taxes)	Premium	Premium	Premium	PRESIDENT; SCIENTIFIC SOFTWARE
2024-03-05	Premium	sold (taxes)	Premium	Premium	Premium	SVP AND GENERAL COUNSEL
2024-03-05	Premium	sold (taxes)	Premium	Premium	Premium	PRESIDENT, CHIEF COMMERCAL OFF
2024-03-05	Premium	acquired	Premium	Premium	Premium	SVP AND GENERAL COUNSEL
2024-03-05	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER

CERT - Certara, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for CERT